Cogentix Medical

Company

Investment-firm

Last deal

$25.M

Amount

Post-IPO Equity

Stage

16.09.2016

Date

1

all rounds

$25.M

Total amount

General

About Company
Cogentix Medical develops and sells medical devices for minimally invasive treatments.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1987

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Cogentix Medical is a global medical device company that specializes in developing and manufacturing products for the minimally invasive treatment of voiding dysfunctions and endoscopy solutions. Their products include the Urgent® PC Neuromodulation System, which provides non-drug, non-surgical treatment for Overactive Bladder and associated symptoms. They also offer Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence, and EndoSheath® Endoscopy, a solution that combines advanced endoscopic technology with a sterile, disposable microbial barrier. These products have improved treatment efficiency and reduced patient risk. Cogentix Medical was formed in 2015 through the merger of Uroplasty and Vision-Sciences.
Contacts